Rajan Sah MD
Adult Congenital Heart Disease
Instructor in Medicine, Brigham and Women's Hospital
Join to View Full Profile
1 Barnes Jewish Hospital Plz# DivSaint Louis, MO 63110
Phone+1 314-362-1291
Fax+1 314-362-4278
Dr. Sah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2006 - 2009
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2006
University of Toronto Faculty of MedicineClass of 2004
Certifications & Licensure
MO State Medical License 2019 - 2026
IA State Medical License 2013 - 2019
MA State Medical License 2006 - 2015
American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Endothelial cell Piezo1 promotes vascular smooth muscle cell differentiation on large arteries.Javier Abello, Ying Yin, Yonghui Zhao, Josh Maurer, Jihui Lee
European Journal of Cell Biology. 2025-03-01 - Endothelial cell Piezo1 promotes vascular smooth muscle cell differentiation on large arteries.Javier Abello, Ying Yin, Yonghui Zhao, Josh Maurer, Jihui Lee
Biorxiv. 2024-06-12 - Mechanosensing in Metabolism.John D Tranter, Ashutosh Kumar, Vinayak K Nair, Rajan Sah
Comprehensive Physiology. 2023-12-29
Press Mentions
Research Roundup: All About Antibodies and a Neuroprotective EnzymeFebruary 18th, 2022- New Compound Improves Insulin Secretion and Lowers Blood Sugar in Treated MiceFebruary 16th, 2022
- Diabetes, Metabolic Syndrome in Mice Treated Using Novel Compound ClassFebruary 15th, 2022
- Join now to see all
Grant Support
- LRRC8 complex regulation of endothelial functionWASHINGTON UNIVERSITY2023–2027
- Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetesWASHINGTON UNIVERSITY2021–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Principles in Cardiovascular Research Training ProgramWASHINGTON UNIVERSITY1975–2026
- Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 DiabetesSENSEION THERAPEUTICS, INC.2021–2025
- SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolismWASHINGTON UNIVERSITY2021–2025
- Tuning Adipocyte Size and Obesity through SWELL1WASHINGTON UNIVERSITY2016–2025
- Tuning Adipocyte Size and Obesity through SWELL1WASHINGTON UNIVERSITY2016–2025
- Tuning Adipocyte Size and Obesity through SWELL1WASHINGTON UNIVERSITY2016–2025
- Tuning Adipocyte Size and Obesity through SWELL1WASHINGTON UNIVERSITY2016–2025
- Tuning Adipocyte Size and Obesity through SWELL1WASHINGTON UNIVERSITY2016–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
